Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: Towards epitope-driven therapies

Journal of the American Society of Nephrology

Volumn 17, Issue 7, 2006, Pages 1772-1774

  Ronco, Pierre ^b   Debiec, Hanna ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; MEGALIN; MEMBRANE METALLOENDOPEPTIDASE;

ANTIBODY DETECTION; ANTIGEN DETECTION; CD8+ T LYMPHOCYTE; EDITORIAL; EPITOPE MAPPING; HEYMANN NEPHRITIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMBRANOUS GLOMERULONEPHRITIS; PODOCYTE; PRIORITY JOURNAL;

EID: 33745861027     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050497     Document Type: Editorial

References (32)

1. Glassock RJ: Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23: 324-332, 2003
2. Glassock RJ: The treatment of idiopathic membranous nephropathy. A dilemma or a conundrum? Am J Kidney Dis 44: 562-566, 2004
3. Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Dis 44: 385-401, 2004
4. Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G: Rituximab in idiopathic membranous nephropathy: A one-year prospective study. J Am Soc Nephrol 14: 1851-1857, 2003
5. Cunningham PN, Quigg RJ: Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 16: 1214-1222, 2005
6. Couser WG: Membranous nephropathy: A long road but well traveled. J Am Soc Nephrol 16: 1184-1187, 2005
7. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL: Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspension. Proc Soc Exp Biol Med 100: 660-664, 1959
8. Kerjaschki D, Farquhar MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A 79: 5557-5561, 1982
9. Kerjaschki D, Farquhar MG: Imrnunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 157: 667-686, 1983
10. Tramontano A, Knight T, Vizzuso D, Makker SP: Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis. J Am Soc Nephrol 17: 1979-1985, 2006
11. Pietromonaco S, Kerjaschki D, Binder S, Ullrich R, Farquhar MG: Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc Natl Acad Sci U S A 87: 1811-1815, 1990
12. Kerjaschki D, Ullrich R, Diem K, Pietromonaco S, Orlando RA, Farquhar MG: Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc Natl Acad Sci U S A 89: 11179-11183, 1992
13. Saito A, Pietromonaco S, Loo AKC, Farquhar MG: Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor family. Proc Natl Acad Sci U S A 91: 9725-9729, 1994
14. Raychowdhury R, Niles JL, McCluskey RT, Smith JA: Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244: 1163-1165, 1989
15. Christensen EI, Birn H: Megalin and cubilin: Multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256-266, 2002
16. Kerjaschki D, Ullrich R, Exner M, Orlando RA, Kerjaschki D, Ullrich R, Exner M, Orlando RA, Farquhar MG: Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein. J Exp Med 183: 2007-2015, 1996
17. Huang J, Makker SP: Role of receptor-associated 39/45 kD protein in active Heymann nephritis. Kidney Int 47: 432-441, 1995
18. Raychowdhury R, Zheng G, Brown D, McCluskey RT: Induction of Heymann nephritis with a gp330/megalin fusion protein. Am J Pathol 148: 1613-1623, 1996
19. Saito A, Yamazaki H, Rader K, Nakatani A, Ullrich R, Kerjaschki D, Orlando RA, Farquhar MG: Mapping rat megalin: The second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc Natl Acad Sci U S A 93: 8601-8605, 1996
20. Yamazaki H, Ullrich R, Exner M, Saito A, Orlando RA, Kerjaschki D, Farquhar MG: All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J Am Soc Nephrol 9: 1638-1644, 1998
21. Oleinikov AV, Feliz BJ, Makker SP: A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. J Am Soc Nephrol 11: 57-64, 2000
22. Tramontano A, Makker SP: Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. J Immunol 172: 2367-2373, 2004
23. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschenes G, Ronco PM: Antenatal membranous glomerulonephritis due to ana-neutral endopeptidase antibodies. N Engl J Med 346: 2053-2060, 2002
24. Debiec H, Nauta J, Coulet F, van der Burg M, Guigonis V, Schurmans T, de Heer E, Soubrier F, Janssen F, Ronco P: Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 364: 1252-1259, 2004
25. Turner AJ, Isaac RE, Coates D: The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function. Bioessays 23: 261-269, 2001
26. Nortier JL, Debiec H, Tournay Y, Mougenot B, Noel JC, Deschodt-Lanckman MM, Janssen F, Ronco P: Neonatal disease in neutral endopeptidase alloimmunization: Lessons for pregnancy management and immunological monitoring. Pediatric Nephrol 2006, in press
27. Ronco P, Debiec H: Molecular pathomechanisms of membranous nephropathy: From Heymann nephritis to alloimmunization. J Am Soc Nephrol 16: 1205-1213, 2005
28. Medgyesi GA, Fust G, Gergely J, Bazin H: Classes and subclasses of rat immunoglobulins: Interaction with the complement system and with staphylococcal protein A. Immunochemistry 15: 125-129, 1978
29. Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA: Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 100: 2303-2309, 1997
30. Harrison LC, Hafler DA: Antigen-specific therapy for autoimmune disease. Curr Opin Immunol 12: 704-711, 2000
31. Mayer L, Shao L: Therapeutic potential of oral tolerance. Nat Rev Immunol 4: 407-419, 2004
32. Reynolds J, Prodromidi EI, Juggapah JK, Abbott DS, Holthaus KA, Kalluri R, Pusey CD: Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 16: 1350-1359, 2005